Expression of cyclin D1 after treatment with doxorubicin in the HL-60 cell line

Low-dose etoposide-treatment induces endoreplication and cell death accompanied by cytoskeletal alterations in A549 cells: Does the response involve senescence? The possible role of vimentin

(2013) Anna Litwiniec et al.   Cancer Cell International

Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death

(2012) Arpad M. Danos et al.   CANCER LETTERS

Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin

(2012) Agnieszka Żuryń et al.   CELL BIOLOGY INTERNATIONAL

Cleistanthoside A tetraacetate-induced DNA damage leading to cell cycle arrest and apoptosis with the involvement of p53 in lung cancer cells

(2012) Podchanart Wanitchakool et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A novel carbazole derivative, MHY407, sensitizes cancer cells to doxorubicin-, etoposide-, and radiation treatment via DNA damage

(2012) Sungpil Yoon et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons

(2012) Prashant Kumar Modi et al.   MOLECULAR BIOLOGY OF THE CELL

Bioactive Phytochemical Proanthocyanidins Inhibit Growth of Head and Neck Squamous Cell Carcinoma Cells by Targeting Multiple Signaling Molecules

(2012) Ram Prasad et al.   PLoS One

Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model

(2011) Min Wei et al.   CANCER SCIENCE

Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines

(2011) Katrin Tiemann et al.   LEUKEMIA & LYMPHOMA